Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)
Toxicologic Pathology · 2026-10 · 54 (7) · 486-502
DOI: 10.1177/01926233261439119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 14.05.2026. Verfasst von Julie F Foley und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Environmental Health Sciences, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Fluorocarbons, Placenta, Caprylates, Maternal Exposure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, Intramural NIH HHS, University of North Carolina at Chapel Hill.
Abstract (Originalsprache)
Exposure to certain per- and polyfluoroalkyl substances (PFAS) is associated with adverse pregnancy outcomes in mice and humans. These adverse outcomes are suspected to be due to exposure-related toxic effects on the placenta. This study was designed to more explicitly define the effects of selected PFAS on all regions of the placenta of pregnant CD-1 mice. Pregnant CD-1 mice were gavaged with perfluorooctanoic acid (PFOA; 1 or 5 mg/kg-d) or hexafluoropropylene oxide dimer acid (GenX; 2 or 10 mg/kg/day) from embryonic day (E) 1.5 to E17.5. Exposure to either PFOA or GenX resulted in higher placenta weights and lower placental efficiency (embryo:placenta weight ratio). Light microscopic evaluation of the placentae revealed treatment-associated lesions in the decidua, junctional zone, and labyrinth. The reduced placental efficiency and microscopic findings were consistent with maternal vascular malperfusion. With few exceptions, there were no differences between the effects of PFOA when compared with GenX, except for increased necrosis of spongiotrophoblasts in the high-dose PFOA-treated group. Taken together, these findings suggest both PFOA and GenX cause multiple pathological changes at the microscopic and tissue level of the placenta consistent with adverse maternal-fetal health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Environmental Health Sciences, Durham, North Carolina, USA.
- Charles River Laboratories, Inc., Durham, North Carolina, USA.
- U.S. Environmental Protection Agency, Durham, North Carolina, USA.
- North Carolina State University, Raleigh, North Carolina, USA.
ORCID-Profile: Catherine A Picut, Vesna A Chappell, Bevin E Blake
Förderung
- NIEHS NIH HHS
- Intramural NIH HHS
- University of North Carolina at Chapel Hill
- National Institutes of Health
- National Institute of Environmental Health Sciences
Zitieren
APA
Foley, J. F., Picut, C. A., Chappell, V. A., Miller, C. N., Fenton, S. E., & Blake, B. E. (2026). Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX). Toxicologic Pathology, 54(7), 486-502. https://doi.org/10.1177/01926233261439119
Vancouver
Foley JF, Picut CA, Chappell VA, Miller CN, Fenton SE, Blake BE. Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX). Toxicologic Pathology. 2026;54(7):486-502. doi:10.1177/01926233261439119
BibTeX
@article{Foley2026,
author = {Foley, Julie F and Picut, Catherine A and Chappell, Vesna A and Miller, Colette N and Fenton, Suzanne E and Blake, Bevin E},
title = {Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)},
journal = {Toxicologic Pathology},
year = {2026},
volume = {54},
number = {7},
pages = {486--502},
doi = {10.1177/01926233261439119}
}
EUVIMED